<DOC>
	<DOCNO>NCT00698646</DOCNO>
	<brief_summary>The purpose study evaluate safety efficacy initial treatment therapy valsartan/hydrochlorothiazide ( HCTZ ) versus initial treatment therapy monotherapies ( valsartan HCTZ ) elderly patient ( great equal 70 year ) stage 1 2 hypertension</brief_summary>
	<brief_title>Efficacy Safety Valsartan/Hydrochlorothiazide Combination Compared Valsartan Monotherapy Hydrochlorothiazide Monotherapy Elderly ( &gt; 70 ) With Mild-moderate Hypertension .</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Hydrochlorothiazide</mesh_term>
	<mesh_term>Valsartan</mesh_term>
	<criteria>Age 70 year old . Patients hypertension prior randomize study . Patients must office cuff MSSBP ≥ 140 ≤ 200 mmHg systolic . Have ability communicate comply study requirement . Provide write informed consent participate study prior screen study procedure . Use investigational drug within 30 day enrollment . History hypersensitivity study drug drug similar chemical class . Office blood pressure measure office machine cuff mean ( 3 ) MSDBP ≥ 120 mmHg anytime screen / washout period . Patients take 3 antihypertensive drug MSSBP ≥ 160 mmHg time Visit 1 . Other protocoldefined exclusion criterion may apply</criteria>
	<gender>All</gender>
	<minimum_age>70 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2011</verification_date>
	<keyword>Systolic blood pressure</keyword>
	<keyword>Diastolic blood pressure</keyword>
	<keyword>Valsartan</keyword>
	<keyword>Hydrochlorothiazide</keyword>
</DOC>